Storey, Philip P <br/><br/>
Rhegmatogenous Retinal Detachment after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor.  [electronic resource] 

 -  Ophthalmology  10 2019 
 - 1424-1431 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1549-4713 
<br/><br/><label>Standard No.: </label>10.1016/j.ophtha.2019.04.037  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--adverse effects<br/>Bevacizumab--adverse effects<br/>Female<br/>Humans<br/>Intravitreal Injections--adverse effects<br/>Male<br/>Middle Aged<br/>Ranibizumab--adverse effects<br/>Receptors, Vascular Endothelial Growth Factor<br/>Recombinant Fusion Proteins--adverse effects<br/>Retinal Detachment--drug therapy<br/>Retinal Vein Occlusion--drug therapy<br/>Retrospective Studies<br/>Risk Factors<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors